Wealthspire Advisors LLC Has $1.19 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Wealthspire Advisors LLC lowered its stake in Aflac Incorporated (NYSE:AFLFree Report) by 3.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,373 shares of the financial services provider’s stock after selling 491 shares during the quarter. Wealthspire Advisors LLC’s holdings in Aflac were worth $1,194,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Norges Bank acquired a new position in shares of Aflac during the 4th quarter worth about $197,820,000. Strategic Financial Concepts LLC grew its holdings in Aflac by 7,001.0% during the second quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock valued at $596,000 after purchasing an additional 658,303 shares during the period. Swedbank AB bought a new stake in Aflac in the first quarter valued at approximately $27,588,000. Schroder Investment Management Group raised its holdings in Aflac by 196.5% in the fourth quarter. Schroder Investment Management Group now owns 484,176 shares of the financial services provider’s stock worth $39,945,000 after purchasing an additional 320,867 shares during the period. Finally, Cetera Investment Advisers boosted its position in shares of Aflac by 161.0% during the first quarter. Cetera Investment Advisers now owns 311,239 shares of the financial services provider’s stock worth $26,723,000 after purchasing an additional 191,975 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Up 0.6 %

AFL stock opened at $108.59 on Monday. The company has a market cap of $60.81 billion, a price-to-earnings ratio of 11.99, a P/E/G ratio of 2.53 and a beta of 0.95. Aflac Incorporated has a twelve month low of $74.89 and a twelve month high of $111.14. The business has a 50 day moving average price of $101.04 and a two-hundred day moving average price of $91.04. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFLGet Free Report) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $4.10 billion. During the same period last year, the business earned $1.58 earnings per share. The firm’s revenue was down .7% on a year-over-year basis. Analysts anticipate that Aflac Incorporated will post 6.75 EPS for the current fiscal year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 annualized dividend and a yield of 1.84%. Aflac’s dividend payout ratio (DPR) is currently 22.08%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on AFL shares. Barclays assumed coverage on shares of Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective for the company. Piper Sandler raised their price target on Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, June 28th. Wells Fargo & Company boosted their price objective on Aflac from $81.00 to $90.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Truist Financial raised their target price on shares of Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, JPMorgan Chase & Co. upped their price target on shares of Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a report on Tuesday, July 2nd. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $92.50.

Get Our Latest Stock Analysis on Aflac

Insider Buying and Selling

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Recommended Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.